KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Liabilities and Shareholders Equity (2016 - 2025)

Boston Scientific's Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $43.7 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 10.86% year-over-year to $43.7 billion; the TTM value through Dec 2025 reached $125.4 billion, up 218.24%, while the annual FY2025 figure was $43.7 billion, 10.86% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $43.7 billion at Boston Scientific, up from $41.6 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $43.7 billion in Q4 2025 and bottomed at $31.9 billion in Q3 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $33.8 billion (2023), against an average of $35.8 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity increased 0.74% in 2022 before it rose 12.12% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $32.2 billion in 2021, then grew by 0.74% to $32.5 billion in 2022, then grew by 8.21% to $35.1 billion in 2023, then grew by 12.12% to $39.4 billion in 2024, then grew by 10.86% to $43.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Liabilities and Shareholders Equity are $43.7 billion (Q4 2025), $41.6 billion (Q2 2025), and $40.1 billion (Q1 2025).